IL-12 protects mice against pulmonary and disseminated infection caused by <i>Cryptococcus neoformans</i>
-
- K Kawakami
- First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan
-
- M Tohyama
- First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan
-
- Q Xie
- First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan
-
- A Saito
- First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus, Okinawa, Japan
抄録
<jats:title>SUMMARY</jats:title> <jats:p>We examined the role of IL-12 in host resistance to Cryptococcus neoformans using a murine model of pulmonary and disseminated infection. In this model, mice were infected intratracheally with viable yeast cells. Mice untreated with IL-12 allowed an uncontrolled multiplication of yeast cells in the lung with infiltrations of few inflammatory cells, and a cryptococcal dissemination to the brain and meningitis by 3 weeks, resulting in death of all animals within 4–6 weeks. IL-12, when administered from the day of tracheal infection for 7 days, induced a marked infiltration of inflammatory cells, consisting mostly of mononuclear cells, and significantly reduced the number of viable yeast cells in the lung. The treatment suppressed brain dissemination, as shown by a marked reduction of yeast cells in the brain and prevention of meningitis. These effects resulted in a significant increase in the survival rate of infected mice. In contrast, late administration of IL-12 commencing on day 7 after instillation of yeast cells failed to protect the mice against infection with C. neoformans. In further experiments, early administration of IL-12 markedly induced interferon-gamma (IFN-γ) mRNA in the lungs of infected mice, while no IFN-γ mRNA was detected without this treatment. Our results indicate that IL-12 is effective when administered in the early period of pulmonary cryptococcal infection.</jats:p>
収録刊行物
-
- Clinical and Experimental Immunology
-
Clinical and Experimental Immunology 104 (2), 208-214, 1996-05
Oxford University Press (OUP)
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1363951795067640320
-
- NII論文ID
- 30015017722
-
- ISSN
- 13652249
- 00099104
- http://id.crossref.org/issn/00099104
-
- データソース種別
-
- Crossref
- CiNii Articles